Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zynex (ZYXI)
NASDAQ:ZYXI
ZYXI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.15 - $13.77
Previous CloseN/A
Volume7.23K
Average Volume (3M)64.90K
Market Cap
$243.94M
Enterprise Value$298.89M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)50.8
Beta1.40
Next Earnings
Feb 27, 2025EPS Estimate
0.09Last Dividend Ex-Date
Jan 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding31,845,545
10 Day Avg. Volume77,181
30 Day Avg. Volume64,902
Standard Deviation0.16
R-Squared0.03
Alpha0.00348
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.26
Price to Cash Flow (P/CF)8.60
P/FCF Ratio8.70
Enterprise Value/Market Cap1.23
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda22.34
Forecast
1Y Price Target
$14.00Price Target Upside86.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionIf cleared by the FDA, NiCO would allow Zynex to enter the multi-billion dollar pulse oximetry market with differentiating precision and accuracy.
Product InnovationThe NiCO pulse oximeter uses laser-based technology to measure hemoglobin accurately, even in populations with darker skin pigmentation, which is a significant improvement over current LED pulse oximeters.
Bears Say
Regulatory RisksThere is a potential risk of inability to secure regulatory clearance for other medical devices.
---
Ownership Overview
46.39% Insiders
7.76% Mutual Funds
3.26% Other Institutional Investors
36.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZYXI FAQ
What was Zynex’s price range in the past 12 months?
Zynex lowest stock price was $7.15 and its highest was $13.77 in the past 12 months.
What is Zynex’s market cap?
Zynex’s market cap is $243.94M.
When is Zynex’s upcoming earnings report date?
Zynex’s upcoming earnings report date is Feb 27, 2025 which is in 6 days.
How were Zynex’s earnings last quarter?
Zynex released its earnings results on Oct 24, 2024. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.057 by $0.013.
Is Zynex overvalued?
According to Wall Street analysts Zynex’s price is currently Undervalued.
Does Zynex pay dividends?
Zynex pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zynex dividends here
What is Zynex’s EPS estimate?
Zynex’s EPS estimate is 0.09.
How many shares outstanding does Zynex have?
Zynex has 31,845,545 shares outstanding.
What happened to Zynex’s price movement after its last earnings report?
Zynex reported an EPS of $0.07 in its last earnings report, beating expectations of $0.057. Following the earnings report the stock price went up 6.17%.
Which hedge fund is a major shareholder of Zynex?
Currently, no hedge funds are holding shares in ZYXI
---
Zynex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (86.17% Upside)
$14.00 (86.17% Upside)
Blogger Sentiment
Bullish
ZYXI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 42.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 3.8%
Last 30 Days ▲ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.83%
12-Months-Change
Fundamentals
Return on Equity
10.23%
Trailing 12-Months
Asset Growth
-16.75%
Trailing 12-Months
Company Description
Zynex
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.
---
ZYXI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view with substantial achievements in revenue growth, new product launches, and cash flow improvements. However, these were countered by flat overall revenue, a decline in net income and device revenue, and uncertainties in the strategic review process.Read More>---
ZYXI Stock 12 Month Forecast
Average Price Target
$14.00
▲(86.17% Upside)
Technical Analysis
Best Analysts Covering ZYXI
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-10.18%
reiterated a buy rating 3 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -10.18% per trade.
---